SpaceX targets $1.75trn IPO as investors question the price
SpaceX wants to raise up to $75bn at $135 a share, but critics say the fixed-price deal may leave buyers overpaying before book building even starts.
19 briefings · “ipo”
SpaceX wants to raise up to $75bn at $135 a share, but critics say the fixed-price deal may leave buyers overpaying before book building even starts.

The filing fixes SpaceX at 555.6 million shares at $135 apiece, while Musk still controls 82.4% of voting power and public buyers get a sliver of the float.

A fixed $135 IPO roadshow price would put SpaceX at $1.75 trillion, a milestone that reshuffles how founders, boards, and public-market investors compare private and listed giants.

Anthropic’s breakneck growth is impressive, but its next proving ground is whether those numbers hold up under public-market scrutiny.

Index providers are rewriting entry rules for giant IPOs, which could push retirement funds into SpaceX and Anthropic sooner than most savers expect.

A listing primed for 12 June could value SpaceX at $1.77tn, reshaping the private markets playbook and the wealth math around Elon Musk.

Brett Winton is anchoring ARK's SpaceX thesis on Starlink, a signal that satellite broadband is now being treated like core infrastructure, not moonshot fluff.

Gwynne Shotwell’s role as president and COO shows how SpaceX is balancing Musk’s volatility with the operational discipline investors expect before a public listing.

Elon Musk’s company is leaning into a market debut, and the latest prospectus suggests its ambitions are real even as questions linger.

A single sentence in SpaceX’s amended IPO filing suggests the company may use richly priced stock for massive acquisitions, including a possible Tesla deal.

The quantum computing company chose a traditional IPO over the SPAC-heavy path, signaling a bid for mainstream credibility that other founders and boards will be watching closely.

SpaceX's updated IPO prospectus puts Elon Musk's shares above $866 billion, sharpening the stakes for investors, rivals, and boards watching private-market valuations.